The Zacks Analyst Blog Highlights: Caterpillar, McDonald's, 3M, Procter & Gamble and Johnson & Johns
The Zacks Analyst Blog Highlights: Caterpillar, McDonald's, 3M, Procter & Gamble and Johnson & Johnson
These Drugs Are Actually Moving The Needle For Johnson & Johnson
Sales for its hepatitis C drug are falling off a cliff, but revenue from these fast-growing therapies more than make up for it.
Why TransEnterix, Inc. Shares Are Soaring Today
Rumors of a potential acquisition continue to cause shares to pop and drop.
The Single Best Stock to Own Today
Don't settle for anything less than having this company in your portfolio.
Johnson & Johnson Wants Investors to Ignore Falling Hepatitis C Drug Sales
Olysio's flash-in-the-pan success may be unfairly and negatively skewing investors' perception of Johnson & Johnson's performance.